Monday, February 17, 2014

17/02/14: Delousing medicine effects on cod; Fish to 2030 report; acquisition of aquaculture vaccine assets

A recent study by the National Institute of Nutrition and Seafood Research (NIFES), Bergen, Norway has determined that the delousing agent diflubenzuron is not damaging to Cod. 

“We are aware that the use of diflubenzuron has increased, and that this substance can be distributed in the environment, so we wanted to study its effects on fish species that we know feed near sea-cages; in this case, Cod,” says Bjørn Tore Lunestad, a NIFES scientist.
Full news available here.

Fish farms will provide nearly two thirds of the global food fish supply by 2030.

This was among a report by the World Bank Group, Food and Agriculture Organisation of the United Nations (FAO) and the International Food Policy Research Institute (IFPRI) called “Fish to 2030: Prospects for Fisheries and Aquaculture,” released recently.
View a PDF version of the report here

UK based biotechnology firm Benchmark Holdings PLC has acquired the aquaculture vaccine and development assets of American animal health company Zoetis Inc in a deal worth US$3m in cash.

As part of the deal, Benchmark have also acquired a worldwide license to utilise Zoetis' research and knowledge in order to drive the development of the aquaculture vaccines.
Full news available here




File:Portrait of Cod.jpg
Portrait of cod (Photo credit: Wikipedia)






No comments:

Post a Comment